AbbVie AB is a pharmaceutical company based in Stockholm, Sweden. It is a subsidiary of AbbVie Inc., a global biopharmaceutical company that was established in 2013 as a spin-off from Abbott Laboratories. AbbVie focuses on the research, development, and commercialization of advanced therapies in various therapeutic areas, including immunology, oncology, neuroscience, and virology.
The company is involved in the production of a range of medications and treatments aimed at addressing complex health issues. AbbVie AB contributes to the global pharmaceutical landscape through its commitment to innovation and scientific research, working to develop new therapies that improve patient outcomes. The company also engages in collaborations and partnerships with other organizations to enhance its research capabilities and expand its portfolio of products.
AbbVie AB adheres to regulatory standards and guidelines in its operations, ensuring that its products meet safety and efficacy requirements. The company is part of a larger network of AbbVie operations worldwide, which allows for a collaborative approach to drug development and distribution.